The NF-κB pathway: Regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs

Molecular and Cellular Biochemistry

Volumn 383, Issue 1-2, 2013, Pages 29-37

  Cao, Yongjun ^a,b   Zhou, Xiaomei ^a,b   Liu, Huihui ^a   Zhang, Yanlin ^a   Yu, Xiaoyan ^a,b   Liu, Chunfeng ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Atherosclerosis; Fibrin(ogen); Fibrinogen degradation products; Matrix metalloproteinase; Nuclear factor kappa B; Vascular endothelial growth factor

Indexed keywords

FIBRIN; FIBRINOGEN; GELATINASE A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ENDOTHELIUM CELL; MALE; NONHUMAN; RABBIT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER;

ORYCTOLAGUS CUNICULUS;

ANIMALS; ENDOTHELIAL CELLS; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; GENE EXPRESSION REGULATION; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 8; NF-KAPPA B; PLAQUE, ATHEROSCLEROTIC; RABBITS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885429830     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1751-2     Document Type: Article

References (33)

1. Fukujima MM, Martinez TL, Pinto LE, Auriemo Cdo R, de Andrade LA (1997) Fibrinogen as independent risk factor for ischemic stroke. Arq Neuropsiquiatr 55:737-740
2. Mauriello A, Sangiorgi G, Palmieri G, Virmani R, Holmes DR Jr, Schwartz RS, Pistolese R, Lppoliti A, Spagnoli LG (2000) Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation 101:744-750
3. Reinhart WH (2003) Fibrinogen - marker or mediator of vascular disease? Vasc Med 8:211-216
4. Levenson J, Giral P, Megnien JL, Gariepy J, Plainfosse MC, Simon A (1997) Fibrinogen and its relations to subclinical extracoronary and coronary atherosclerosis in hypercholesterolemic men. Arterioscler Thromb Vasc Biol 17:45-50
5. Koenig W (1999) Fibrinogen and coronary risk. Curr Cardiol Rep 1:112-118
6. Packard CJ, O'Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GD (2000) Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 343:1148-1155
7. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Deguchi H, Mori Y, Kaneko T, Deguchi K, Fujii J, Shiku H (1996) Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol 51:255-260
8. Gaffney PJ, Edgell T, Creighton-Kempsford LJ, Wheeler S, Tarelli E (1995) Fibrin degradation product (FnDP) assays: analysis of standardization issues and target antigens in plasma. Br J Haematol 90:187-194
9. Tashiro K, Shimokama T, Haraoka S, Tokunaga O, Watanabe T (1994) Endothelial cell heterogeneity in experimentally-induced rabbit atherosclerosis. Demonstration of multinucleated giant endothelial cells by scanning electron microscopy and cell culture. Virchows Arch 425:521-529
10. Cao YJ, Wu YH, Liu CF (2008) Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system. Zhonghua Xin Xue Guan Bing Za Zhi 36:62-67
11. Cao YJ, Qian JJ, Liu CF, Zhang ZL, Huo HM (2007) Establishment of the coculture systems of rabbit aortic endothelial cells and smooth muscle cells. Zhongguo Ying Yong Sheng Li Xue Za Zhi 23:509-512
12. Chen HF, Pu XD, Lin YZ, Lin LF, Wu ZY (2004) Dynamic changes of MMP-2, TIMP-2 mRNA after balloon injure in aortic arteries of rabbits. J Clin Cardiol (China) 20:685-687
13. Zhu Y, Liu ZL (2003) A comparison of the mRNA expression of VEGF and its receptor FLK-1 in rabbit iris pigment epithelium cells and retinal pigment epithelial cells. Zhonghua Yan Ke Za Zhi 39:660-663
14. Inoue K, Cynshi O, Kawabe Y, Nakamura M, Miyauchi K, Kimura T, Daida H, Hamakubo T, Yamaguchi H, Kodama T (2002) Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliac artery after balloon denudation in cholesterol-fed rabbits. Atherosclerosis 161:353-363
15. Amorino GP, Hoover RL (1998) Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol 152:199-207
16. Jiang B, Zhang YL, Zhou DY (1996) Basic methods in molecular biology. People's Military Medical Press, Beijing
17. Cao YJ, Liu CF (2005) Vascular endothelial growth factor, matrix metalloproteinase-2, -8 and the instability of atherosclerotic plaques. Foreign Med Sci Cerebrovasc Dis 10:770-773
18. Cao YJ, Qian JJ, Liu CF (2008) The localization coexpression of matrix metalloproteinase-2, -8 and vascular endothelial growth factor in human unstable carotid atherosclerosis plaques. Chin J Neurol 41:102-105
19. Lorenzet R, Sobel JH, Bini A, Witte LD (1992) Low molecular weight fibrinogen degradation products stimulate the release of growth factors from endothelial cells. Thromb Haemost 68:357-363
20. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58:1048-1051
21. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT, Stetler-Stevenson WG, Froehlich J, Lakatta EG (1996) Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 148:121-128
22. Glass CK, Witztum JL (2001) Atherosclerosis: the road ahead. Cell 104:503-516
23. Herman MP, Sukhova GK, Libby P, Gerdes N, Tang N, Horton DB, Kilbride M, Breitbart RE, Chun M, Schonbeck U (2001) Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104:1899-1904
24. Molloy KJ, Thompson MM, Jones JL, Schwalbe EC, Bell PR, Naylor AR, Loftus IM (2004) Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity. Circulation 110:337-343
25. Men BZ, Zhou DB, Shi HY, Zhang XM (2004) The expression of MMP-8 in the atherosclerotic carotid plaques. Chin J Neurosci 20:231-233
26. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P (1999) Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99:2503-2509
27. Ferry G, Lonchampt M, Pennel L, de Nanteuil G, Canet E, Tucker GC (1997) Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett 402:111-115
28. Risau W (1997) Mechanisms of angiogenesis. Nature 386:671-674
29. Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG (1999) Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468-474
30. Hilliard B, Samoilova EB, Liu TS, Rostami A, Chen Y (1999) Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells. J Immunol 163:2937-2943
31. Collins T (1993) Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest 68:499-508
32. Cao YJ, Qian JJ, Liu CF (2006) Fibrin(ogen), its degradation products and their motif antagonist and atherosclerosis. Int J Cerebrovasc Dis 14:290-293
33. Tsakadze NL, Zhao Z, D'Souza SE (2002) Interactions of intercellular adhesion molecule-1 with fibrinogen. Trends Cardiovasc Med 12:101-108